1ST DETECT SECURES FIRST PURCHASE ORDER FOR TSA APPROVED TRACER 1000™ ETDs
Astrotech (NASDAQ: ASTC) announced that its subsidiary 1st Detect has secured its first purchase order for TRACER 1000™ explosive trace detectors (ETDs) from Intuitive Research and Technology , a TSA contractor. The order is valued at $429K and is expected to be recognized in FY2025.
The TRACER 1000, powered by Astrotech Mass Spectrometer Technology™, is the first TSA-approved ETD utilizing mass spectrometry technology. This breakthrough enables laboratory-level analysis with near-zero false alarms and an unlimited detection library, making previously laboratory-confined mass spectrometry technology practical for field use.
Astrotech (NASDAQ: ASTC) ha annunciato che la sua controllata 1st Detect ha ottenuto il suo primo ordine di acquisto per i rivelatori di tracce esplosive TRACER 1000™ da Intuitive Research and Technology, un appaltatore della TSA. L'ordine è valutato 429.000 dollari e si prevede che venga riconosciuto nell'anno fiscale 2025.
Il TRACER 1000, alimentato dalla tecnologia Astrotech Mass Spectrometer Technology™, è il primo rivelatore di tracce esplosive approvato dalla TSA che utilizza la tecnologia della spettrometria di massa. Questa innovazione consente un'analisi a livello di laboratorio con quasi zero falsi allarmi e una biblioteca di rilevamento illimitata, rendendo pratica l'applicazione della tecnologia di spettrometria di massa precedentemente confinata ai laboratori per l'uso sul campo.
Astrotech (NASDAQ: ASTC) anunció que su subsidiaria 1st Detect ha asegurado su primer pedido de compra para los detectores de trazas explosivas TRACER 1000™ de Intuitive Research and Technology, un contratista de la TSA. El pedido está valorado en 429.000 dólares y se espera que se reconozca en el año fiscal 2025.
El TRACER 1000, impulsado por la tecnología Astrotech Mass Spectrometer Technology™, es el primer detector de trazas explosivas aprobado por la TSA que utiliza tecnología de espectrometría de masas. Este avance permite un análisis a nivel de laboratorio con casi cero falsas alarmas y una biblioteca de detección ilimitada, lo que hace que la tecnología de espectrometría de masas, antes confinada a laboratorios, sea práctica para su uso en campo.
Astrotech (NASDAQ: ASTC)는 자회사인 1st Detect가 TSA 계약업체인 Intuitive Research and Technology로부터 TRACER 1000™ 폭발물 탐지기(ETD)의 첫 구매 주문을 확보했다고 발표했습니다. 주문 금액은 429,000 달러이며, FY2025에 반영될 것으로 예상됩니다.
Astrotech Mass Spectrometer Technology™로 구동되는 TRACER 1000은 질량 분석 기술을 이용한 최초의 TSA 승인 ETD입니다. 이 혁신은 거의 제로의 잘못된 경고와 무한한 탐지 라이브러리를 통해 실험실 수준의 분석을 가능하게 하며, 기존에 실험실에 한정되었던 질량 분석 기술을 현장에서도 실용적으로 사용할 수 있게 합니다.
Astrotech (NASDAQ: ASTC) a annoncé que sa filiale 1st Detect a sécurisé sa première commande d'achat pour les détecteurs de traces explosives TRACER 1000™ de Intuitive Research and Technology, un sous-traitant de la TSA. La commande est évaluée à 429 000 dollars et devrait être reconnue au cours de l'exercice 2025.
Le TRACER 1000, alimenté par la technologie Astrotech Mass Spectrometer Technology™, est le premier détecteur de traces explosives approuvé par la TSA utilisant la technologie de spectrométrie de masse. Cette avancée permet une analyse de niveau laboratoire avec quasiment zéro faux positifs et une bibliothèque de détection illimitée, rendant la technologie de spectrométrie de masse, auparavant confinée aux laboratoires, pratique pour une utilisation sur le terrain.
Astrotech (NASDAQ: ASTC) gab bekannt, dass ihre Tochtergesellschaft 1st Detect ihren ersten Auftrag für TRACER 1000™ Explosivstoffspuren-Detektoren (ETDs) von Intuitive Research and Technology, einem TSA-Auftragnehmer, erhalten hat. Der Auftrag hat einen Wert von 429.000 US-Dollar und wird voraussichtlich im Geschäftsjahr 2025 anerkannt.
Der TRACER 1000, betrieben mit Astrotech Mass Spectrometer Technology™, ist der erste von der TSA genehmigte ETD, der Massenspektrometrie-Technologie nutzt. Dieser Durchbruch ermöglicht Laboranalysen mit nahezu null Fehlalarmen und einer unbegrenzten Detektionsbibliothek, wodurch die bisher im Labor eingeschlossene Massenspektrometrie-Technologie praktisch für den Einsatz im Feld wird.
- Secured first purchase order worth $429K for TSA-approved TRACER 1000™ ETDs
- First-to-market with TSA-approved mass spectrometry-based ETD technology
- Product offers near-zero false alarms and unlimited detection library capability
- None.
Insights
This
The TRACER 1000™'s mass spectrometry technology addresses critical pain points in cargo screening:
- Near-zero false alarms significantly reduce costly secondary screenings and operational delays
- Unlimited detection library provides future-proof adaptability to emerging threats
- Laboratory-grade accuracy in a field-deployable format enables superior threat detection
While the initial order size is modest relative to the
The successful commercialization of mass spectrometry in a practical, field-deployable format represents a significant technological achievement that could be leveraged into adjacent security and industrial applications. This diversification potential, combined with the recurring revenue opportunity from consumables and maintenance, suggests broader long-term value creation beyond the initial hardware sales.
AUSTIN, Texas, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Astrotech Corporation (NASDAQ: ASTC) announced today that its 1st Detect subsidiary has received a purchase order for its TRACER 1000™ explosive trace detectors (ETDs) from Intuitive Research and Technology Corporation (INTUITIVE®) a TSA contractor. The purchase order is valued at
INTUITIVE is an aerospace engineering and analysis firm who works closely with the TSA, the Department of Defense, and other State and Federal Government agencies to deliver solutions to various customers in the defense, commercial and governmental sectors. INTUITIVE’s Valparaiso Integration Facility allows engineers and experts to collaborate, design and evaluate innovative solutions.
“This is a major milestone for the Company as our first TSA Approved Tracer 1000 ETD sale. We look forward to introducing our near zero false alarm mass spectrometry-based trace detection to the U.S. cargo market,” said Thomas B. Pickens III, Chairman and Chief Executive Officer of 1st Detect.
The Astrotech Mass Spectrometer Technology™ (AMS Technology) drives the breakthrough TRACER 1000, the first TSA approved ETD to employ mass spectrometry. Recognized as the gold standard in chemical detection, mass spectrometry has historically been too costly, bulky, and cumbersome to be used outside of the laboratory. AMS Technology allows for lab level analysis resulting in near-zero false alarms and an unlimited library.
About Astrotech Corporation
Astrotech (Nasdaq: ASTC) is a mass spectrometry company that launches, manages, and commercializes scalable companies based on its innovative core technology through its wholly-owned subsidiaries. 1st Detect develops, manufactures, and sells trace detectors for use in the security and detection market. AgLAB develops and sells chemical analyzers for use in the agriculture market. Pro-Control is developing the mass spectrometry technology for use in chemical manufacturing processes. BreathTech is developing a breath analysis tool to screen for volatile organic compounds that could indicate infections or critical conditions. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.
Forward-Looking Statements
This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, the adverse impact of inflationary pressures, including significant increases in fuel costs, global economic conditions and events related to these conditions, including the ongoing wars in Ukraine and the middle east and the COVID-19 pandemic, the Company’s use of proceeds from the common stock offerings, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, whether the market will accept our products and services and whether we are successful in identifying, completing and integrating acquisitions, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including the Company’s most recent Annual Report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. While we do not intend to directly harvest, manufacture, distribute or sell cannabis or cannabis products, we may be detrimentally affected by a change in enforcement by federal or state governments and we may be subject to additional risks in connection with the evolving regulatory area and associated uncertainties. Any such effects may give rise to risks and uncertainties that are currently unknown or amplify others mentioned herein. Although the Company believes the expectations reflected in its forward-looking statements are reasonable and are based on reasonable assumptions, no assurance can be given that these assumptions are accurate or that any of these expectations will be achieved (in full or at all) or will prove to have been correct. Moreover, such statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond the control of the Company, which may cause actual results to differ materially from those implied or expressed by the forward-looking statements. In addition, any forward- looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to correct or update these forward-looking statements, whether as a result of new information, future events or otherwise, except as required by applicable law.
Company Contact: Jaime Hinojosa, Chief Financial Officer, Astrotech Corporation, (512) 485-9530
FAQ
What is the value of ASTC's first TRACER 1000™ purchase order?
When will ASTC recognize revenue from the TRACER 1000™ purchase order?
What makes ASTC's TRACER 1000™ ETD unique in the market?